购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Apoptosis
    (1)
  • Others
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (1)
  • 20日内发货
    (1)
  • 8-10周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "9 cis retinoic acid"的结果
筛选
搜索结果
TargetMol产品目录中 "

9 cis retinoic acid

"的结果
  • 抑制剂&激动剂
    2
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    2
    TargetMol | Recombinant_Protein
  • 9-cis-Retinoic Acid
    Alitretinoin, 9-顺式视黄酸
    T214975300-03-8
    9-cis-Retinoic Acid (Alitretinoin) 是一种维生素 A 的衍生物,是一种 RAR RXR 激动剂,具有抗癌、抗肿瘤活性、抗炎和神经保护活性,可诱导细胞凋亡 (apoptosis),调节细胞周期,可用于研究晚期肿瘤。
    • ¥ 789
    In stock
    规格
    数量
  • agn 193109 sodium
    CD3106
    T852832319838-82-7
    AGN 193109 is a potent antagonist of retinoic acid receptors (RARs; Kd= 2, 2, and 3 nM for RARα, β, and γ, respectively), exhibiting selectivity for RARs over retinoid X receptors (RXRs; Kd= >10,000 nM for human RXRα, β, and γ receptors). This compound effectively reverses cellular morphology changes and growth suppression induced by RAR agonists such as all-trans-RA, 13-cis-RA, and 9-cis-RA in ECE16-1 human endometrial ectocervical epithelial cells, particularly when used at a 10-fold molar excess. Furthermore, AGN 193109 downregulates the expression of cytokeratin K5-8, 13, 14, 16, 17, and 19 genes, indicating inhibition of retinoid action, specifically when co-administered with TTNPB but not as a standalone treatment. In vivo studies demonstrate teratogenic effects, including cleft palate, frontonasal dysplasia, and eye malformations in mouse fetuses following a single oral dose of 1 mg kg.
    • 待询
    8-10周
    规格
    数量